Immediate Postpartum Glucose Tolerance Testing

Description

The objective of this study is to compare the accuracy of a 2hr glucose tolerance test administered during the postpartum hospitalization with the standard of care glucose tolerance testing (administered at 6 weeks postpartum). The primary hypothesis is that the glucose tolerance test administered in the postpartum period will be accurate and will improve compliance with postpartum testing for gestational diabetics.

Conditions

Gestational Diabetes

Study Overview

Study Details

Study overview

The objective of this study is to compare the accuracy of a 2hr glucose tolerance test administered during the postpartum hospitalization with the standard of care glucose tolerance testing (administered at 6 weeks postpartum). The primary hypothesis is that the glucose tolerance test administered in the postpartum period will be accurate and will improve compliance with postpartum testing for gestational diabetics.

Immediate Postpartum Glucose Tolerance Testing Among Gestational Diabetics: A Comparison to the Gold Standard

Immediate Postpartum Glucose Tolerance Testing

Condition
Gestational Diabetes
Intervention / Treatment

-

Contacts and Locations

Long Beach

Long Beach Memorial Medical Center/Miller Children's and Women's Hospital, Long Beach, California, United States, 90806

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Pregnant or recently postpartum (postpartum day 0 or 1)
  • * ≥ 18 years of age
  • * Gestational age ≥34 weeks
  • * A1 or A2 gestational diabetes
  • * Medical exclusion from completing glucose tolerance testing
  • * Steroid administration within 10 days prior to enrollment
  • * Chronic steroid use

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

MemorialCare Health System,

Kenneth Chan, MD, PRINCIPAL_INVESTIGATOR, Magella Medical Group

Study Record Dates

2025-07-01